Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hye-Youn | - |
dc.contributor.author | Kim, Jinhee | - |
dc.contributor.author | Huyen Trang Ha Thi | - |
dc.contributor.author | Bang, Ok-Sun | - |
dc.contributor.author | Lee, Won-Suk | - |
dc.contributor.author | Hong, Suntaek | - |
dc.date.available | 2020-02-27T23:44:31Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2016-11-18 | - |
dc.identifier.issn | 1472-6882 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7684 | - |
dc.description.abstract | Background: KIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts. Our preliminary study identified that BP3B exhibited potent anti-proliferative activity against various types of cancer cell lines in vitro. Because the in vivo anti-tumor effect of BP3B is not evaluated before clinical trial, we want to test it using patient's samples. Methods: To confirm the in vivo anti-cancer effect of BP3B, we used genetically characterized patient-derived colon tumor xenograft (PDTX) mouse model. Anti-cancer activity was evaluated with apoptosis, proliferation, angiogenesis and histological analysis. Results: Oral administration of BP3B significantly inhibited the tumor growth in two PDTX models. Furthermore, TUNEL assay showed that BP3B induced apoptosis of tumor tissues, which was associated with degradation of PARP and Caspase 8 and activation of Caspase 3. We also observed that BP3B inhibited cancer cell proliferation by down-regulation of Cyclin D1 and induction of p27 proteins. Inhibition of angiogenesis in BP3B-treated group was observed with immunofluorescence staining using CD31 and Tie-2 antibodies. Conclusion: These findings indicated that BP3B has a strong growth-inhibitory activity against colon cancer in in vivo model and will be a good therapeutic candidate for treatment of refractory colon cancer. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BIOMED CENTRAL LTD | - |
dc.relation.isPartOf | BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.subject | PEUCEDANUM-PRAERUPTORUM DUNN | - |
dc.subject | ADVANCED COLORECTAL-CANCER | - |
dc.subject | INDEPENDENT PROGNOSTIC INDICATOR | - |
dc.subject | DESCURAINIA-SOPHIA | - |
dc.subject | ALNUS-JAPONICA | - |
dc.subject | 1ST-LINE TREATMENT | - |
dc.subject | BREAST-CARCINOMA | - |
dc.subject | PROSTATE-CANCER | - |
dc.subject | CELL LINES | - |
dc.subject | PHASE-II | - |
dc.title | Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000388339500001 | - |
dc.identifier.doi | 10.1186/s12906-016-1447-8 | - |
dc.identifier.bibliographicCitation | BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, v.16 | - |
dc.identifier.scopusid | 2-s2.0-84996557459 | - |
dc.citation.title | BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.citation.volume | 16 | - |
dc.contributor.affiliatedAuthor | Kim, Hye-Youn | - |
dc.contributor.affiliatedAuthor | Kim, Jinhee | - |
dc.contributor.affiliatedAuthor | Lee, Won-Suk | - |
dc.contributor.affiliatedAuthor | Hong, Suntaek | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | BP3B | - |
dc.subject.keywordAuthor | Colon cancer | - |
dc.subject.keywordAuthor | Patient-derived tumor xenograft | - |
dc.subject.keywordAuthor | Medicinal plant | - |
dc.subject.keywordPlus | PEUCEDANUM-PRAERUPTORUM DUNN | - |
dc.subject.keywordPlus | ADVANCED COLORECTAL-CANCER | - |
dc.subject.keywordPlus | INDEPENDENT PROGNOSTIC INDICATOR | - |
dc.subject.keywordPlus | DESCURAINIA-SOPHIA | - |
dc.subject.keywordPlus | ALNUS-JAPONICA | - |
dc.subject.keywordPlus | 1ST-LINE TREATMENT | - |
dc.subject.keywordPlus | BREAST-CARCINOMA | - |
dc.subject.keywordPlus | PROSTATE-CANCER | - |
dc.subject.keywordPlus | CELL LINES | - |
dc.subject.keywordPlus | PHASE-II | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.